Does TMS Work? An Honest Guide to Response and Remission in Connecticut

Does TMS work for depression?

Transcranial magnetic stimulation (TMS) can help some people with major depressive disorder, particularly when depression has not improved enough with medication, talking therapy or both. It is not a guaranteed treatment, and it does not work in the same way for every person.

TMS uses magnetic pulses applied to specific areas of the scalp. The pulses are intended to influence brain networks involved in mood. Treatment is usually carried out while a person is awake and able to return home afterwards.

TMS was cleared by the US Food and Drug Administration for major depressive disorder in 2008. In 2021, FDA clearance also covered depression with comorbid anxiety. These clearances mean the treatment has met regulatory standards for the specified uses; they do not mean that every patient will respond.

The most honest answer is that TMS works well enough for some people to experience a meaningful reduction in depression symptoms, and for some to reach remission. Others notice only partial change, no clear benefit, or improvement that does not last. A proper assessment can help establish whether TMS is a reasonable option, but it cannot predict an individual outcome with certainty.

What do “response” and “remission” mean?

TMS research often uses two terms that can sound similar but describe different outcomes: response and remission.

A response usually means that a person’s depression symptoms have reduced substantially from where they started. In clinical trials, this is commonly defined as at least a 50% reduction on a recognised depression rating scale.

A person may be considered a responder while still having some symptoms. For example, they may be sleeping better, finding daily tasks more manageable and experiencing fewer low-mood days, but still have low energy, reduced motivation or occasional distressing thoughts.

Remission is a stricter outcome. It generally means that depression symptoms have fallen to a very low level on a rating scale, with little current impact on daily life. It does not necessarily mean that every difficult feeling has disappeared, or that future episodes of depression are impossible. Rather, it indicates that the person is no longer meeting the usual threshold for a current depressive episode, or has very few remaining symptoms.

In everyday terms:

• No meaningful benefit: symptoms remain much the same.
• Partial improvement: some symptoms ease, but depression is still significantly present.
• Response: symptoms reduce substantially.
• Remission: symptoms become minimal or largely absent.

These categories are helpful for research and treatment planning, but they cannot capture every aspect of recovery. A rating scale may improve before someone feels ready to return to work, reconnect socially or resume activities they value. Equally, a person may describe meaningful changes in daily life that are not fully reflected by a questionnaire.

What do published TMS trials report?

Published trials and later clinical studies support TMS as an effective treatment option for some people with depression, including people whose depression has not responded adequately to previous treatments.

Results are commonly reported as the proportion of participants who achieve response or remission by the end of treatment. Across studies, outcomes vary considerably. This is partly because studies do not always include the same types of patients, use the same TMS protocol, or define follow-up periods in the same way.

For that reason, it is more useful to understand published findings in broad terms than to rely on a single headline percentage. Trials show that:

• some participants have substantial symptom improvement;
• some reach remission;
• some have a partial response;
• some do not experience a meaningful benefit during the treatment course.

Trials may compare active TMS with a sham treatment, while real-world clinic studies may examine outcomes in people receiving routine care. People taking part in a tightly controlled trial may differ from people seeking treatment in Connecticut clinics. For example, they may have different levels of treatment resistance, co-occurring anxiety, physical health needs or medication changes during treatment.

When reviewing results, it is also worth asking what the study measured. A short-term reduction in symptoms is important, but so are functioning, quality of life, safety, whether benefits continue after treatment, and what support is available if symptoms return.

Why individual results vary

Depression is not one identical condition. It can involve different symptom patterns, causes, severity levels and life circumstances. This is one reason why two people receiving apparently similar TMS treatment may have different outcomes.

Factors that may affect results include:

• how long depression has been present and how severe it is;
• previous treatments and whether they provided any benefit;
• whether anxiety, trauma symptoms, substance use, chronic pain or other mental health conditions are also present;
• physical health, sleep and day-to-day stress;
• medication use and whether medicines change during the course;
• the TMS protocol, target area and treatment schedule;
• whether treatment sessions are attended consistently;
• ongoing support, including therapy, social support and practical help.

A clinician should also consider whether symptoms could be related to another condition requiring a different approach. TMS is not suitable for everyone, including some people with certain implanted or metallic medical devices near the head. A provider can discuss safety in relation to an individual’s medical history.

Timing matters

TMS is usually delivered as a course rather than a one-off appointment. A standard course is often around 36 weekday sessions over roughly six to nine weeks, although plans can differ.

Improvement may be gradual. Some people notice early changes in sleep, concentration, anxiety or ability to get through the day before they feel a clear shift in mood. Others do not notice improvement until later in the course. It is also possible to complete treatment without the hoped-for change.

This can make mid-treatment conversations important. The treating clinician may use symptom questionnaires alongside a person’s own account of how they are coping. If there is limited improvement, they may discuss whether the current plan remains appropriate and what other options should be considered.

TMS is often one part of a wider depression care plan. It may be used alongside medication, psychotherapy and practical support, depending on the person’s needs and clinical advice.

Side effects and expectations

TMS is generally delivered without sedation or anaesthesia. The most common side effects are scalp discomfort during treatment and headache afterwards. These are often manageable, but should be discussed with the treatment team if they are troublesome.

Seizure is a rare risk. A provider should review relevant medical history, current medicines and other factors before treatment begins.

A realistic expectation is not that TMS will instantly remove all symptoms. A more useful goal is to understand what meaningful improvement would look like for you: fewer depressive symptoms, greater ability to function, a return to important routines, or relief sufficient to engage more fully with other treatment and support.

Finding TMS care in Connecticut

TMS Therapy Connecticut currently lists 75 published clinics across the state. Directory listings include clinics in communities such as Glastonbury, Greenwich, Hartford, Milford, Fairfield, Stamford, West Hartford, Danbury, Norwich, Groton, Plainville and Farmington.

Availability, referral requirements and treatment approaches can differ between providers. Before choosing a clinic, consider asking:

• whether the provider assesses treatment-resistant depression and co-occurring anxiety;
• what treatment schedule they recommend and why;
• how they monitor symptoms during treatment;
• what happens if symptoms do not improve;
• whether they offer follow-up or maintenance planning;
• what your insurer requires for authorisation.

Insurance arrangements should always be checked directly with both the clinic and insurer. Plans commonly encountered in Connecticut include Anthem Blue Cross Blue Shield Connecticut, ConnectiCare, Aetna, Cigna, UnitedHealthcare / Oxford, HUSKY Health, Medicare including Advantage plans, and TRICARE East. Coverage can depend on the individual plan, diagnosis, previous treatment history, provider status and prior authorisation requirements.

Getting help in Connecticut

Use the TMS Therapy Connecticut clinic listings to compare local providers, the insurance guide to understand possible coverage questions, and the contact page if you need help navigating the directory.

This is educational information, not medical advice.